CG
KRRO icon

Cutler Group’s Korro Bio KRRO Stock Holding History

Cutler Group’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18
Closed -$3K – 6048
2021
Q2 		$3K Sell
18
-502
-97% -$245K ﹤0.01% 4787
2021
Q1 		$340K Buy
520
+426
+453% +$828K 0.02% 936
2020
Q4 		$1K Buy
+94
New +$124K ﹤0.01% 4468

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cutler Group's KRRO Position: Q4 2023 in Review

Cutler Group sold out of Korro Bio (KRRO) in Q4 2023, closing a stake of 136 shares — an estimated $2K sold.

Cutler Group first reported a position in KRRO in Q4 2020 and held it in 12 quarters. The position peaked at $216K in Q1 2021. 40 funds tracked by Wall St. Rank hold KRRO as of Q4 2023.

  • Cutler Group reported no remaining Korro Bio position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 136 Korro Bio shares in Q4 2023, an estimated $2K.
  • Cutler Group first reported a position in Korro Bio in Q4 2020 and held it in 12 quarters.
  • Cutler Group's Korro Bio position peaked at $216K in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Korro Bio as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.